Voyager Therapeutics
Price & Volume
Stats
See more52W Range | $2.75-$9.55 |
Market Cap | $174.4M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $80M |
Revenue Growth (YoY) | -93% |
Gross Profit (12 Mos) | -$47.3M |
Diluted EPS | -$1.13 |
News
See moreYahoo Finance • 21 days ago
Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025
Yahoo Finance • last month
Bragar Eagel & Squire, P.C. Is Investigating Dave, Red Cat, Perpetua, and Voyager and Encourages Investors to Contact the Firm
Yahoo Finance • last month
Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
Yahoo Finance • 2 months ago
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast
About
CEO | Dr. Alfred W. Sandrock Jr., M.D., Ph.D. |
Address | 75 Hayden Avenue, Lexington, MA, United States, 02421 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 172 |
